secwatch.observer — SEC 8-K summary
======================================

Issuer:     Finch Therapeutics Group, Inc. (FNCHQ)
CIK:        0001733257
Form:       8-K
Filed at:   2021-10-19T23:59:59+00:00
Accession:  0000950170-21-002176
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Finch Therapeutics posts Jefferies IBD Summit slides; no new material disclosures
--------------------------------------------------------------------------------

- Furnished slides under Item 7.01 for Jefferies Virtual Next Generation IBD Therapeutics Summit held October 2021.
- Presentation titled 'Harnessing the Genomic Revolution & Machine Learning to Pioneer Microbiome Therapeutics'.
- No financial results, guidance, or pipeline updates provided in the filing.
- Slides available on company website under Events & Presentations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1733257/000095017021002176/0000950170-21-002176-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1733257/000095017021002176/fnch-20211019.htm
  HTML page:      https://secwatch.observer/filing/0000950170-21-002176

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer